LOGAN, Utah, Nov. 5, 2020 /PRNewswire/ — Quansys Biosciences announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based IgG antibody test. A positive IgG antibody result identifies patients who have been exposed to the SARS-CoV-2 virus and, as part of their recovery, demonstrated an adaptive immune response.
The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) Assay simultaneously detects human IgG antibodies that recognize the S1 and S2 subunits of the SARS-CoV-2 spike protein from the same sample. The S1 subunit is of particular interest as it contains the receptor binding domain necessary for viral entry into human cells, and the viral domain associated with neutralizing antibodies. The accuracy of testing for the S1 subunit alone was adequate for EUA requirements, nonetheless, adding the S2 subunit measurement to the clinical call increased accuracy to 97.4% sensitivity and 99.7% specificity. Tests offering a high level of specificity result in fewer false positive calls, which is vital when disease prevalence is low. “High quality tests are essential as we work to better control the SARS-CoV-2 pandemic. In addition, improved quality and accuracy of the assay is vital to correctly evaluate the spread of this virus, which varies across communities,” noted Adam Brown, CEO of Quansys Biosciences.
The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) Assay is available for immediate use. Sites adopting this assay are quickly guided to optimal capacity by the highly competent Quansys Assay Technical Team. Quansys’ manufacturing capabilities and supply chain are designed to meet high volume demand. The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) assay can be ordered directly from Quansys Biosciences.
About Quansys Biosciences
Quansys Biosciences develops and manufactures fully customized multiplex ELISA kits that help researchers, vaccine and drug developers, and government agencies learn more about inflammatory responses and disease states. The company was founded in 2005 and are experts at developing multiplex immunoassays. For more information on the assay, visit www.quansysbio.com.
Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.
WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.
MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.
COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.
A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.